Paul Liknaitzky Lab

Welcome to
The Clinical Psychedelic Research Lab

The Clinical Psychedelic Research Lab is establishing a rigorous program of research in psychedelic medicine at Monash University that seeks to evaluate therapeutic effects, innovate on treatment design, mitigate known risks, explore potential drawbacks, and understand therapeutic mechanisms.

The Lab is led by Dr Paul Liknaitzky.

The Lab is part of the School of Psychological Sciences within the Turner Institute for Brain and Mental Health, and the Department of Psychiatry within the School of Clinical Sciences.

Latest announcement - MDMA therapist training complete

September 2021: Congratulations to the MMP-1 trial therapists for completing their MDMA-assisted therapy training program this month! Also, a big thank you to our partners and colleagues at The Multidisciplinary Association for Psychedelic Studies (MAPS) for developing and delivering an excellent therapist training program. This is the first time MAPS has run their training program in collaboration with an Australian group. Eighteen qualified clinicians from our group, each with a wealth of mental healthcare experience, participated in this training. They will work on the MMP-1 clinical trial in our lab, treating 25 Australians with PTSD using MDMA-assisted therapy. MAPS will provide ongoing mentorship and clinical supervision to our trial therapists.

Find out more